SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽Demo🎬Demo VideoℹVision

What are the optimal oxygen pressure, duration, and frequency parameters for HBOT in AD treatment?

PARTIALLY ADDRESSED

The abstract explicitly states that further investigation is imperative to determine optimal HBOT parameters. This knowledge gap directly limits clinical translation of a promising therapeutic intervention for AD. Gap type: open_question Source paper: Oxygen metabolism abnormality and Alzheimer's disease: An update. (None, None, PMID:37956598)

Priority: 0.87 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What are the optimal oxygen pressure, duration, and frequency parameters for HBOT in AD treatment? is a 0.87 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What are the optimal oxygen pressure, duration, and frequency parameters for HBOT in AD treatment? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
1
Debates
0.68
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (3)

HBOT→TFEBHBOT→PPARGC1AHBOT→NFE2L2

associated with (16)

entities-histone-methylation→ADentities-ros→ADentities-atp7b-gene→ADTDP-43→ADTAU→AD
▸ Show 11 more

biomarker for (1)

tau cleavage products→AD

causes (6)

AD→neurodegenerationPHOSPHORYLATED_TAU→ADBETA_AMYLOID→ADAD→memory_lossAD→DEMENTIA
▸ Show 1 more

cross disease mechanism in (5)

MAPT→ADTREM2→ADNLRP3→ADPINK1→ADGRN→AD

depleted in (1)

SPM_levels→AD

improves (1)

HBOT→cognitive function

inhibits (1)

HBOT→NLRP3

modulates (1)

HBOT→microglial M2 polarization

prevents (2)

HBOT→neuroinflammationNAD+ augmentation→AD

protective against (1)

cognitive stimulation→AD

restores (1)

HBOT→neurovascular coupling

risk factor for (4)

genetically at-risk individuals→ADAPOE ε4→ADAPOE4→ADmicroglial priming→AD

targets (1)

resveratrol→AD

therapeutic target for (6)

CCR2→ADTREM2→ADSaracatinib→ADlevetiracetam→ADNAD+ augmentation→AD
▸ Show 1 more
🕑 Activity Feed
✏ update on knowledge_gap by None 2026-04-25T22:15
🎭 What are the optimal oxygen pressure, duration, and frequenc q=0.68 2026-04-25T19:32
✏ update on knowledge_gap by None 2026-04-25T19:32
✏ update on knowledge_gap by None 2026-04-25T19:32
✏ update on knowledge_gap by None 2026-04-22T14:14
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps